Amelioration of non-alcoholic fatty liver disease by sodium butyrate is linked to the modulation of intestinal tight junctions in db/db mice.

Food & Function
Tingting YangXiaoxing Yin

Abstract

The intestinal microenvironment, a potential factor that contributes to the development of non-alcoholic fatty liver disease (NALFD) and type 2 diabetes (T2DM), has a close relationship with intestinal tight junctions (TJs). Here, we show that the disruption of intestinal TJs in the intestines of 16-week-old db/db mice and in high glucose (HG)-cultured Caco-2 cells can both be improved by sodium butyrate (NaB) in a dose-dependent manner in vitro and in vivo. Accompanying the improved intestinal TJs, NaB not only relieved intestine inflammation of db/db mice and HG and LPS co-cultured Caco-2 cells but also restored intestinal Takeda G-protein-coupled (TGR5) expression, resulting in up-regulated serum GLP-1 levels. Subsequently, the GLP-1 analogue Exendin-4 was used to examine the improvement of lipid accumulation in HG and free fatty acid (FFA) co-cultured HepG2 cells. Finally, we used 16-week-old db/db mice to examine the hepatoprotective effects of NaB and its producing strain Clostridium butyricum. Our data showed that NaB and Clostridium butyricum treatment significantly reduced the levels of blood glucose and serum transaminase and markedly reduced T2DM-induced histological alterations of the liver, together with improved l...Continue Reading

References

Oct 30, 2013·Digestive Diseases and Sciences·Makoto SeoTsugikazu Komoda
May 11, 2015·Metabolism: Clinical and Experimental·Alessandro MantovaniGiovanni Targher
Jun 6, 2015·Digestive Diseases·Tatyana V MasyukNicholas F LaRusso
Jul 8, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Qian LuXiao-Xing Yin
Sep 24, 2015·Journal of Hepatology·Matthew J ArmstrongJeremy W Tomlinson
Jun 4, 2016·Nature Reviews. Rheumatology·Shahla Abdollahi-RoodsazJose U Scher
Jun 9, 2016·Nature Reviews. Gastroenterology & Hepatology·Christopher LeungPeter W Angus
Jan 17, 2017·Cellular and Molecular Gastroenterology and Hepatology·Lucie Etienne-MesminBenoit Chassaing
Jun 27, 2017·Expert Review of Gastroenterology & Hepatology·Maaike Vancamelbeke, Séverine Vermeire
Oct 8, 2017·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Tingting YangZhenzhou Jiang
Dec 1, 2017·Journal of Endocrinological Investigation·M G RadaelliG Perseghin
Jan 24, 2018·Diabetes Care·Alessandro MantovaniGiovanni Targher
Feb 7, 2018·Diabetes & Metabolic Syndrome·Sivabal VanjiappanVadivelan Mehalingam
Apr 24, 2018·Phytotherapy Research : PTR·Yao-Wu LiuTao-Yun Wang
Jun 27, 2018·The Journal of Endocrinology·You-Hua XuQuan Zhu
Jun 28, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Wenqian FengJuxiong Liu
Jul 4, 2018·Nature Medicine·Scott L FriedmanArun J Sanyal
Sep 24, 2018·Drug Discovery Today·Tingting YangZhenzhou Jiang
Oct 3, 2018·Digestive Diseases and Sciences·Veedamali S SubramanianHamid M Said
Oct 21, 2018·Environmental Toxicology and Pharmacology·Yimeng HuYancheng Xu
Oct 26, 2018·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Francesco BifariFranco Folli
Jan 22, 2019·Frontiers in Endocrinology·Emily W L SunDamien J Keating
Mar 8, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Ya-Jing ChenYao-Wu Liu
Apr 28, 2019·Metabolism: Clinical and Experimental·Tingting YangXiaoxing Yin
May 28, 2019·Endocrine, Metabolic & Immune Disorders Drug Targets·Fatemeh KhatamiSeyed M Tavangar
Jun 30, 2019·Journal of Agricultural and Food Chemistry·Wen-Qian ZhangYou-Hua Xu
Aug 9, 2019·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Tine JessKristine H Allin

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
protein assay

Software Mentioned

GraphPad Prism
Image J

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.